ZA764508B - 1,2,3,4.tetrahydrosoquinolines and the preparation thereo - Google Patents

1,2,3,4.tetrahydrosoquinolines and the preparation thereo

Info

Publication number
ZA764508B
ZA764508B ZA764508A ZA764508A ZA764508B ZA 764508 B ZA764508 B ZA 764508B ZA 764508 A ZA764508 A ZA 764508A ZA 764508 A ZA764508 A ZA 764508A ZA 764508 B ZA764508 B ZA 764508B
Authority
ZA
South Africa
Prior art keywords
tetrahydrosoquinolines
thereo
preparation
preparation thereo
Prior art date
Application number
ZA764508A
Other languages
English (en)
Inventor
M Kato
T Kishimoto
I Ueda
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA764508B publication Critical patent/ZA764508B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA764508A 1975-07-28 1976-07-27 1,2,3,4.tetrahydrosoquinolines and the preparation thereo ZA764508B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31570/75A GB1553230A (en) 1975-07-28 1975-07-28 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof

Publications (1)

Publication Number Publication Date
ZA764508B true ZA764508B (en) 1977-07-27

Family

ID=10325102

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA764508A ZA764508B (en) 1975-07-28 1976-07-27 1,2,3,4.tetrahydrosoquinolines and the preparation thereo

Country Status (19)

Country Link
US (1) US4096263A (xx)
JP (1) JPS5217477A (xx)
AR (1) AR212174A1 (xx)
AT (1) AT358588B (xx)
AU (1) AU506715B2 (xx)
BE (1) BE844472A (xx)
CA (1) CA1068276A (xx)
CH (1) CH623310A5 (xx)
DE (1) DE2633692A1 (xx)
DK (1) DK143750C (xx)
ES (1) ES450206A1 (xx)
FR (1) FR2319357A1 (xx)
GB (1) GB1553230A (xx)
IE (1) IE43502B1 (xx)
IT (1) IT1063405B (xx)
MX (1) MX3999E (xx)
NL (1) NL7608319A (xx)
SE (1) SE423233B (xx)
ZA (1) ZA764508B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5734275B2 (xx) * 1973-07-30 1982-07-22
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
JP4889463B2 (ja) * 2006-12-07 2012-03-07 株式会社椿本バルクシステム チェーンコンベヤ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines
JPS5734275B2 (xx) * 1973-07-30 1982-07-22
US3963725A (en) * 1973-07-20 1976-06-15 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
AU506715B2 (en) 1980-01-24
DE2633692A1 (de) 1977-02-17
ES450206A1 (es) 1977-11-16
SE423233B (sv) 1982-04-26
FR2319357B1 (xx) 1978-11-17
CH623310A5 (xx) 1981-05-29
DK143750B (da) 1981-10-05
GB1553230A (en) 1979-09-26
NL7608319A (nl) 1977-02-01
DK336676A (da) 1977-01-29
BE844472A (fr) 1977-01-24
IE43502L (en) 1977-01-28
AU1629076A (en) 1978-02-02
DK143750C (da) 1982-03-29
SE7608453L (sv) 1977-01-29
AT358588B (de) 1980-09-25
US4096263A (en) 1978-06-20
AR212174A1 (es) 1978-05-31
CA1068276A (en) 1979-12-18
ATA552076A (de) 1980-02-15
JPS5217477A (en) 1977-02-09
FR2319357A1 (fr) 1977-02-25
MX3999E (es) 1981-10-28
IE43502B1 (en) 1981-03-11
IT1063405B (it) 1985-02-11

Similar Documents

Publication Publication Date Title
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
NZ183651A (en) Tribalo-n-alkyl-2',4',6'-trinitrodiphenylamines
NZ184529A (en) 5-isopropylidene-7-hydroxy-9-substituted-2,6-methano-3,4,56-tetrahydro-2h-1-benzoxocins and their preparation
IL48624A0 (en) 2,3-dihydroergolines
PH14168A (en) 2,4-pyrrolidinediones
GB1557694A (en) 2,9 dichlorquinacridone
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
ZA764508B (en) 1,2,3,4.tetrahydrosoquinolines and the preparation thereo
AU2468877A (en) 1,4 -dicyanobytene
EG12183A (en) 2-chloro-n-isoproyl-2',3'-imethylacetanilide
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
GB1554021A (en) 4,5-didehydroprostaglandins
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
IL49823A0 (en) 1-acyl-1,2,3,4-tetrahydro-6-quinolinols and their preparation
GB1554925A (en) 2,3-methyl-eneprostaglandins
AU1483576A (en) 16,16-dimethyl-prostaglandins
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
NZ185996A (en) 6, 7-methylene-3-oxo-d-homo-17a-pregna-4, 16-dienes and pharmaceutical compositions
ZA777610B (en) 1,4-oxathianes and the preparation thereof
AU1346176A (en) 1,2,3,4-tetrahydro-4-oxo-%or-oxy-<-1-naphthylureas
PH16286A (en) 1,2-dihydro-6-phenyl-1h,4h-imidazo-benzodiazepin-1-ones
CS191036B1 (en) 4,./10/-gonadienes and method for the preparation thereof